Edition:
United States

People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

83.90USD
11:00am EDT
Change (% chg)

$0.01 (+0.01%)
Prev Close
$83.89
Open
$84.05
Day's High
$84.29
Day's Low
$83.79
Volume
179,207
Avg. Vol
1,069,898
52-wk High
$86.71
52-wk Low
$64.25

Runge, Marschall 

Dr. Marschall S. Runge, M.D., Ph.D., is Independent Director of the Company. Dr. Runge is the Executive Dean for the School of Medicine at the University of North Carolina at Chapel Hill. In his role as Executive Dean for the UNC School of Medicine, Dr. Runge provides overall academic and clinical leadership for the School of Medicine and the UNC Health Care System. In addition to being the Chair of the Department of Medicine, Dr. Runge is also Principal Investigator and Director of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at UNC-Chapel Hill, where he has financial, human resource and strategic oversight responsibilities for the program. An honors graduate of Vanderbilt University with a B.A. in Biology and a Ph.D. in molecular biology, Dr. Runge earned his M.D. from the Johns Hopkins School of Medicine, where he was an intern and resident in internal medicine. He then completed a cardiology fellowship at Harvard's Massachusetts General Hospital and was a faculty member there prior to moving to Emory University as an Associate Professor of Medicine in 1989. Before joining the UNC faculty in 2000, Dr. Runge held the John Sealy Distinguished Centennial Chair in Internal Medicine and was Director of the Division of Cardiology and the Sealy Center for Molecular Cardiology at the University of Texas Medical Branch at Galveston. In addition to serving as a member of the Experimental Cardiovascular Sciences Study Section of the National Institutes of Health, Dr. Runge also has published over 150 peer-reviewed manuscripts.

Basic Compensation

Total Annual Compensation, USD 123,500
Restricted Stock Awards, USD 160,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 283,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --